Oesophageal Disorders Flashcards
Gastro-oesophageal reflux disease (GORD) may be defined as
symptoms of oesophagitis secondary to refluxed gastric contents
NICE recommend that GORD which has not been investigated with endoscopy should be treated as per the dyspepsia guidelines
true
GORD - poor correlation between symptoms and endoscopy appearance
true
Indications for upper GI endoscopy >45 years is an indication
FALSE
>55 years
Indications for upper GI endoscopy:
age > 55 years symptoms > 4 weeks or persistent symptoms despite treatment dysphagia relapsing symptoms weight loss
GORD If endoscopy is negative consider
24-hr oesophageal pH monitoring
GORD gold standard test for diagnosis?
24-hr oesophageal pH monitoring
Management of Endoscopically proven oesophagitis
full dose proton pump inhibitor (PPI) for 1-2 months
if response then low dose treatment as required
if no response then double-dose PPI for 1 month
Management of Endoscopically negative reflux disease
full dose PPI for 1 month
if response then offer low dose treatment, possibly on an as-required basis, with a limited number of repeat prescriptions
if no response then H2RA or prokinetic for one month
H2 RA examoles?
Ranitidine
Complications of GORD include?
oesophagitis ulcers anaemia benign strictures Barrett's oesophagus oesophageal carcinoma
Barrett’s refers to the hyperplasia of the lower oesophageal mucosa
false
metaplasia
Barrett’s usual squamous epithelium being replaced by columnar epithelium
true
Barrett’s increased risk of oesophageal adenocarcinoma, estimated at 50-100 fold
true
Barrett’s can be subdivided into short (<3cm) and long (>3cm). The length of the affected segment correlates strongly with the chances of identifying metaplasia
true
Barrets seen in 12% of those undergoing endoscopy for reflux.
true
Barrets Histological features
the columnar epithelium may resemble that of either the cardiac region of the stomach or that of the small intestine (e.g. with goblet cells, brush border)
Barretts risk factors
gastro-oesophageal reflux disease (GORD) is the single strongest risk factor
male gender (7:1 ratio)
smoking
central obesity
alcohol does not seem to be an independent risk factor for Barrett’s
true
Barretts mx
endoscopic surveillance with biopsies
high-dose proton pump inhibitor - evidence base that this reduces the change of progression to dysplasia or induces regression of the lesion is limited
Endoscopic surveillance in barretts is for patients with ? endoscopy is recommended every ? years
for patients with metaplasia (but not dysplasia) endoscopy is recommended every 3-5 years